Edmund K Waller, MD, PHD
Professor of Medicine, Pathology and Hematology/Oncology
Emory School of Medicine
Associate Director for Clinical Research
Winship Cancer Institute
Director
Division of Stem Cell Transplantation and Immunotherapy
Director
Bone Marrow and Stem Cell Transplant Center
Medical Director
Center for Apheresis, Emory Hospital
Medical Director
Stem Cell Processing Laboratory, Emory Hospital
Dr. Waller earned his undergraduate degree from Harvard University, his medical degree from Cornell University Medical College, and his PhD in chemical biology from Rockefeller University in New York, New York. Dr. Waller completed a residency in the Department of Medicine at Stanford University in Stanford, California. He then went on to complete a clinical fellowship in oncology, as well as a research fellowship in pathology at Stanford University.
Research Interests
Dr. Waller’s research focus is in enhancing immune reconstitution after stem cell transplant and developing cell therapy for anti-tumor immunology and in regenerative medicine. His current research activities include pre-clinical and clinical studies focused on the role of donor immune cells in optimizing anti-tumor immunity after allogenic transplantation, and the clinical application of autologous CD34+ cells in improving vascular function and facilitating neo-angiogenesis in patients with peripheral and coronary vascular disease. His NIH-funded basic research lab uses mouse models and performs immunological analyses of clinical samples from patients. He has active translational research activities and serves as a principal investigator on institutional and national cooperative group clinical trials.
Web Site(s):
Publications
View publications on PubMed
Clinical Trials
View clinical trials at Winship Cancer Institute
Grants
- 06-Don
- 273-08-201
- Clinical Database For Bone Marrow And Peripheral Blood Stem Cell Transplant Outcom
- Comparing Peripheral Blood Stem Cell Transplantation Versus Bone Marrow Transplantation
- Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease in Hematopoetic Stem Cell Transplant Patients
- Development Of A Murine Mage-A3 Vaccine Using An Attenuated Listeria Monocytogenes
- The Effect of Rituximab on Mobilization With AMD3100 (Plerixafor) Plus G-CSF
- Evaluation of the Drug Plerixafor in Combination With Chemotherapy and G-CSF for Stem Cell Collection
- Immunologic And Virologic Effects Of Cmv Pp65 Specific Cytotoxic T Lymphocytes For
- Nv20234 A Double-Blind, Randomized, Stratified, Multi-Ce
- A Phase III, Randomized Double Blind, Placebo-Controlled
- Phase III Randomized, Multicenter Study Comparing G-Csf
- Phase Iii Trial Comparing Sirolimus/Tacrolimus
- Separating Anti-Tumor And Gvhd Effect In Allogeneic T-Cells
- Spectra Optia Apheresis System
- A Study of the Monoclonal Antibody CT-011 in Diffuse Large B-Cell Lymphoma Following Autologous Stem Cell Transplantation
- Tacrolimus/Sirolimus/Methotrexate Versus Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil
- Trial To Evaluate Palifermin In The Reducation Of Acut
- Txa127-2009-001
